Home » Topics » Disease categories and therapies » Substance use and poisoning

Substance use and poisoning
RSS

Second phase IIa study for TA-CD in cocaine dependence reports findings

June 19, 2003

Agents for iron overload therapy disclosed by Novartis researchers

June 3, 2003

Nippon Shinyaku acquires Japanese rights to acamprosate

May 28, 2003

Rat study suggests potential of topiramate in treating nicotine addiction

May 8, 2003

Ilomastat successful in treating exposure to mustard gas

April 24, 2003

Elite develops opioid antagonist product to minimize abuse potential

April 17, 2003

TA-CD enters phase IIa cocaine administration study

April 16, 2003

Evidence for potential of SB-277011-A in drug dependence and psychosis

April 11, 2003

HE-2100 protects nonhuman primates from effects of radiation exposure

April 9, 2003

Enrollment complete in phase III trial of Vivitrex in alcohol dependence

April 3, 2003

Popular Stories

Today's news in brief
BioWorld
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
Keros reports beneficial effects of RKER-065 in ALS model
BioWorld Science
Keros Therapeutics Inc. has presented data regarding their activin receptor ligand trap, RKER-065, for the inhibition of the activin/myostatin signaling axis.
News in brief
BioWorld Asia
BioWorld Asia briefs for March 17, 2026
First-in-class POLG activator restores mtDNA across mutations
BioWorld Science
Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...